These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 582728)

  • 1. Potential antineoplastics. 4th communication: N-mustard derivatives of estrone).
    Hamacher H
    Arzneimittelforschung; 1979; 29(3):463-6. PubMed ID: 582728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Unexpected formation of an estrone derivative from androsta-1,4-diene-3,17-dione].
    Görlitzer K; Bonnekessel Ch; Jones PG; Kaufmann G
    Pharmazie; 2002 Dec; 57(12):808-10. PubMed ID: 12561240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, estrogen receptor binding affinity and biological evaluation of some 2-substituted estrone derivatives.
    Omar AM; AboulWafa OM; Labouta IM; el-Tombary AA; el-Mallah AI
    Farmaco; 1997 Apr; 52(4):219-25. PubMed ID: 9241826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of estrone and 16, 17-pyrazoleestrone on estrogen receptor of the rat uterus].
    Wang NG; Li HP; Zhang JT
    Yao Xue Xue Bao; 1986 Feb; 21(2):98-101. PubMed ID: 3751598
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative analysis of the interaction of various estrogens with the estrogen-receptor system of the uterus].
    Fanchenko ND; Alekseeva ML; Minina LS; Novikov EA; Khel'mun DK
    Biokhimiia; 1985 Nov; 50(11):1853-8. PubMed ID: 4063405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical assays for the selection of cytotoxic-linked estrogens with potential therapeutic activity.
    Leclercq G; Heuson JC
    Cancer Treat Rep; 1978 Aug; 62(8):1255-7. PubMed ID: 688263
    [No Abstract]   [Full Text] [Related]  

  • 7. Contribution to the mechanism of Stilbostat action.
    Görlich M; Heise E
    Neoplasma; 1976; 23(4):363-9. PubMed ID: 1004653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron estrogens: synthesis, biochemical and biological testing of estrone and estradiol-17 beta 3-carboranylmethyl ethers.
    Sweet F
    Steroids; 1981 Feb; 37(2):223-38. PubMed ID: 6939160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The estrogenic activities of 2-[3-estrone-N-ethyl-piperazine-methyl]tetracycline(XW630)--a new compound with anti-osteoporosis activity].
    Mo Z; Jiao X; Su H; Zheng H; Weng L
    Yao Xue Xue Bao; 1998 Sep; 33(9):645-9. PubMed ID: 12016866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of antiestrogenecity of compound CDRI-85/287: a new orally active nonsteroidal antiimplantation agent.
    Sreenivasulu S; Singh MM; Dwivedi A; Setty BS; Kamboj VP
    Indian J Exp Biol; 1992 Nov; 30(11):968-71. PubMed ID: 1293041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile synthesis of cids: biotinylated estrone oximes efficiently heterodimerize estrogen receptor and streptavidin proteins in yeast three hybrid systems.
    Muddana SS; Peterson BR
    Org Lett; 2004 Apr; 6(9):1409-12. PubMed ID: 15101754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthesis and study of B-nor-8-isoanalogs of steroid estrogens].
    Shavva AG; Selivanov SI; Starova GL; Boronoeva TR; Ishchenko IV; Gluzdikov IA; Sharetskiĭ AN; Isaeva VG; Surinov BP
    Bioorg Khim; 2002; 28(3):242-50. PubMed ID: 12077850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possible heterogeneity of cytoplasmic estrogen receptors].
    Alekseeva ML; Minina LS; Novikov EA; Shchedrina RN; Fanchenko ND
    Vopr Med Khim; 1984; 30(5):62-5. PubMed ID: 6528522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein.
    Björk P; Jönsson U; Andrén-Sandberg A
    Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor binding radiopharmaceuticals: II. Tissue distribution of 17 alpha-methylestradiol in normal and tumor-bearing rats.
    Feenstra A; Vaalburg W; Nolten GM; Reiffers S; Talma AG; Wiegman T; van der Molen HD; Woldring MG
    J Nucl Med; 1983 Jun; 24(6):522-8. PubMed ID: 6406650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo interaction between steroidal alkylating agents and oestrogen receptors in rabbit uteri.
    Asai M; Takeuchi H; Okada H
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):173-80. PubMed ID: 579532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and receptor-binding examinations of the normal and 13-epi-D-homoestrones and their 3-methyl ethers.
    Wölfling J; Mernyák E; Frank E; Falkay G; Márki A; Minorics R; Schneider G
    Steroids; 2003 Mar; 68(3):277-88. PubMed ID: 12628691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
    Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ
    J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig.
    Gulino A; Pasqualini JR
    Cancer Res; 1982 May; 42(5):1913-21. PubMed ID: 7066903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.